Introduction to the Central Management Committee (CMC)

The Central Management Committee (CMC) was established during the 26th Meeting of the European Competent Authorities in Liége by the Competent Authorities within the medical devices sector.

The main purpose of its creation is to improve the effectiveness and appropriateness of the regulatory system and ensure its continued development.

It is tasked with providing an improved and effective decision-making, drafting positions, and harmonizing the interpretation of Directives with the main objective of protecting public health taking into account the technological and other developments.

As such, proceedings will normally focus on the progress and development of new technologies and their influence on the medical sector, as well as on the current situation and further steps aimed at amending the regulation applicable to medical devices (Directives 93/42/EEC, 90/385/EEC and 98/79/EC).

The CMC is focused on finding practical solutions to problems or emerging issues identified in other forums (such as the Competent Authority meetings - CAMD) and obtaining Member State agreement to a consistent implementation on a voluntary basis whenever possible. If applicable and more appropriate, the CMC may request the European Commission to adopt legally binding measures in accordance with the applicable directive; such request may be accompanied by proposed drafts for such measures.

The CMC consist of one member per Member State of the European Economic Area (EEA) and European Free Trade Association (EFTA), nominated by the Member State/Competent Authority. For each member a deputy shall be nominated by the Member State/Competent Authority. Candidate Member States and Turkey may contribute with one representative each, with observer status.

Last updated Mar 12, 2012

Contact us now to find out more.

View all Publications